1.Wichmann, O, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009–2010. Eurosurveillance 2010; 15.
2.Valenciano, M, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Medicine 2011; 8: e1000388.
3.Hardelid, P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009–2010. Eurosurveillance 2011; 16.
4.Andrews, N, et al. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. Journal of Infectious Diseases 2011; 203: 32–39.
5.Pebody, R, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Eurosurveillance 2011; 16.
6.Jimenez-Jorge, S, et al. Effectiveness of the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012; 30: 3595–3602.
8.Skowronski, DM, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 2842–2851.
9.Fleming, DM, et al. Estimating Influenza vaccine effectiveness using routinely collected laboratory data. Journal of Epidemiology and Community Health 2010; 64: 1062–1067.
10.Ellis, J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Eurosurveillance 2009; 14: pii = 19230.
11.Gunson, R, et al. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. Journal of Virological Methods 2010; 163: 258–261.
12.van Buuren, S, Groothuis-Oudshoorn, K. mice: multivariate imputation by chained equations. Journal of Statistical Software 2011; 45: 1–67.
13.Ferdinands, JM, et al. Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. Vaccine 2011; 29: 1935–1940.
14.Orenstein, EW, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007; 36: 623–631.
15.Kissling, E, Valenciano, M. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2011; 16.
16.Fielding, JE, et al. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerging Infectious Diseases 2011; 17: 1181–1187.
17.Castilla, J, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Eurosurveillance 2011; 16.
18.Skowronski, DM, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–11 season. Clinical Infectious Diseases. Published online: 21 May 2012. PMID no.: 22539661.
19.Szilagyi, PG, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Archives of Pediatrics & Adolescent Medicine 2008; 162: 943–951.
20.Heinonen, S, et al. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infectious Diseases 2011; 11: 23–29.
21.Eisenberg, KW, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003–2004 and 2004–2005 influenza seasons. Pediatrics 2008; 122: 911–919.
22.Griffin, MR, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6: e23085.
23.Walker, WT, et al. H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study. Clinical Infectious Diseases 2012; 54: 661–669.